Fulfillment of Postmarket Commitments and Requirements for New Drugs Approved by the FDA, 2013-2016.
JAMA Intern Med
; 2022 Oct 03.
Article
in En
| MEDLINE
| ID: mdl-36190713
This cohort study used the Drugs@FDA database to identify new drugs approved by the US Food and Drug Administration (FDA) and assess fulfillment of postmarket commitments and requirements.
Full text:
1
Database:
MEDLINE
Type of study:
Observational_studies
Language:
En
Year:
2022
Type:
Article